Voltage-guided Stepwise Pulmonary Vein Isolation

Voltage-guided Stepwise Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005891

Enrollment

120

Registered

2021-02-15

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Study Protocol 1. Before procedure a. To minimize the effect of antiarrhythmic drugs on the endocardial voltage, amiodarone or other antiarrhythmic drugs (flecainide, propafenone,

30,000 (by Advisor HD Grid SE) D The line for antral ablation should be drawn using only a geometry. E Stepwise ablation • Ablations are perf

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: i. 20 years old ii. who is planned to undergo the radiofrequency catheter ablation (RFCA) for AF

Exclusion criteria

Exclusion criteria: i. prior catheter or balloon ablation for AF ii. history of open-heart surgery iii. diagnosis of unstable angina or myocardial infarction within 3 months iv. Grade III or IV heart failure by New York Heart Association Criteria v. diagnosis of ischemic or hemorrhagic stroke within 6 months vi. <1 year of expectancy

Design outcomes

Primary

Measure	Time frame
1-year atrial fibrillation or atrial tachycardia recurrence-free survival	—

Secondary

Measure	Time frame
1-year atrial fibrillation recurrence-free survival;1-year atrial tachycardia recurrence-free survival;Procedure time;Fluoroscopic time;Ablation time;acute esophageal injury;Procedure-related complications	—

Countries

Korea, Republic of

Contacts

Public ContactKwang-No Lee

Ajou University Hospital

Outcome results